547 related articles for article (PubMed ID: 30588771)
1. Diffusion tensor imaging and disability progression in multiple sclerosis: A 4-year follow-up study.
Kolasa M; Hakulinen U; Brander A; Hagman S; Dastidar P; Elovaara I; Sumelahti ML
Brain Behav; 2019 Jan; 9(1):e01194. PubMed ID: 30588771
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of microstructural abnormalities in multiple sclerosis detected with NODDI and DTI models of diffusion-weighted magnetic resonance imaging.
Caranova M; Soares JF; Batista S; Castelo-Branco M; Duarte JV
Magn Reson Imaging; 2023 Dec; 104():61-71. PubMed ID: 37775062
[TBL] [Abstract][Full Text] [Related]
3. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
[TBL] [Abstract][Full Text] [Related]
4. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
[TBL] [Abstract][Full Text] [Related]
5. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
[TBL] [Abstract][Full Text] [Related]
6. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS.
Alshehri A; Al-Iedani O; Arm J; Gholizadeh N; Billiet T; Lea R; Lechner-Scott J; Ramadan S
Neuroradiol J; 2022 Oct; 35(5):592-599. PubMed ID: 35118885
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Measurements of T
Vavasour IM; Meyers SM; Mädler B; Harris T; Fu E; Li DKB; Traboulsee A; MacKay AL; Laule C
J Neuroimaging; 2019 Jan; 29(1):42-51. PubMed ID: 30230638
[TBL] [Abstract][Full Text] [Related]
8. Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
Saraste M; Bezukladova S; Matilainen M; Sucksdorff M; Kuhle J; Leppert D; Airas L
Mult Scler Relat Disord; 2021 May; 50():102810. PubMed ID: 33556656
[TBL] [Abstract][Full Text] [Related]
9. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures.
Zivadinov R; Bergsland N; Hagemeier J; Carl E; Kolb H; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 May; 388():175-181. PubMed ID: 29627017
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor imaging study of pediatric patients with congenital hydrocephalus: 1-year postsurgical outcomes.
Mangano FT; Altaye M; McKinstry RC; Shimony JS; Powell SK; Phillips JM; Barnard H; Limbrick DD; Holland SK; Jones BV; Dodd J; Simpson S; Mercer D; Rajagopal A; Bidwell S; Yuan W
J Neurosurg Pediatr; 2016 Sep; 18(3):306-19. PubMed ID: 27203134
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
[TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
[TBL] [Abstract][Full Text] [Related]
13. White matter alterations and their associations with motor function in young adults born preterm with very low birth weight.
Hollund IMH; Olsen A; Skranes J; Brubakk AM; Håberg AK; Eikenes L; Evensen KAI
Neuroimage Clin; 2018; 17():241-250. PubMed ID: 29159041
[TBL] [Abstract][Full Text] [Related]
14. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
[TBL] [Abstract][Full Text] [Related]
15. Quantification of normal-appearing white matter damage in early relapse-onset multiple sclerosis through neurite orientation dispersion and density imaging.
Margoni M; Villani U; Silvestri E; Franciotta S; Anglani MG; Causin F; Rinaldi F; Perini P; Bertoldo A; Gallo P
Mult Scler Relat Disord; 2022 Feb; 58():103396. PubMed ID: 35216779
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal microstructural changes of cerebral white matter and their association with mobility performance in older persons.
Moscufo N; Wakefield DB; Meier DS; Cavallari M; Guttmann CRG; White WB; Wolfson L
PLoS One; 2018; 13(3):e0194051. PubMed ID: 29554115
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of clinically isolated syndrome with diffusion tensor imaging and volumetric MRI.
Kolasa M; Hakulinen U; Helminen M; Hagman S; Raunio M; Rossi M; Brander A; Dastidar P; Elovaara I
Clin Imaging; 2015; 39(2):207-12. PubMed ID: 25487438
[TBL] [Abstract][Full Text] [Related]
18. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis of new multiple sclerosis lesions with magnetization transfer and diffusion tensor imaging.
Gloor M; Andelova M; Gaetano L; Papadopoulou A; Burguet Villena F; Sprenger T; Radue EW; Kappos L; Bieri O; Garcia M
Eur Radiol; 2024 Mar; 34(3):1680-1691. PubMed ID: 37658894
[TBL] [Abstract][Full Text] [Related]
20. Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Saraste M; Bezukladova S; Sucksdorff M; Saunavaara V; Rissanen E; Matilainen M; Airas L
Mult Scler Relat Disord; 2021 Feb; 48():102690. PubMed ID: 33352357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
